侵袭性真菌病共识定义修订更新(EORTC/MSGERC)
欧洲癌症研究与治疗组织(EORTC)与美国真菌学教育研究联盟(MSGERC)修订侵袭性真菌病(IFD)共识定义。10个工作组评估影像、实验室诊断和高危特殊人群,经研讨会和3个月公开评议后定稿。确诊、临床诊断和拟诊三类框架不变,但临床诊断定义扩大、拟诊范围缩小,确诊适用于任何患者,临床诊断和拟诊仅限免疫抑制患者(地方性真菌病除外)。
要点
- 确诊IFD定义适用于所有患者,不论是否免疫抑制。
- 临床诊断和拟诊IFD仅限免疫抑制患者,地方性真菌病除外。
- 临床诊断定义扩大,拟诊范围缩小,分类框架不变。
核心结论
- 更新后的IFD共识定义应适用于更广泛高危患者的临床、诊断和流行病学研究。
研究设计与样本
- EORTC/MSGERC组织10个工作组分别聚焦影像、实验室诊断和IFD高危特殊人群,经科学研讨会报告及3个月公开评议后多轮讨论定稿。
主要发现
- 确诊、临床诊断和拟诊IFD的分类框架不变,但临床诊断定义扩大、拟诊范围缩小。
- 确诊IFD可适用于任何患者,不论是否免疫抑制。
- 临床诊断和拟诊仅提议用于免疫抑制患者,地方性真菌病除外。
关键数值与推荐
- 确诊IFD定义适用于任何患者,不论免疫抑制状态。
- 临床诊断和拟诊IFD仅限免疫抑制患者,地方性真菌病除外。
临床怎么用
- 临床和研究中按确诊、临床诊断、拟诊三级分类评估IFD,注意临床诊断和拟诊的免疫抑制人群限定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Invasive fungal diseases (IFDs) remain important causes of morbidity and mortality. The consensus definitions of the Infectious Diseases Group of the European Organization for Research and Treatment of Cancer and the Mycoses Study Group have been of immense value to researchers who conduct clinical trials of antifungals, assess diagnostic tests, and undertake epidemiologic studies. However, their utility has not extended beyond patients with cancer or recipients of stem cell or solid organ transplants. With newer diagnostic techniques available, it was clear that an update of these definitions was essential. METHODS: To achieve this, 10 working groups looked closely at imaging, laboratory diagnosis, and special populations at risk of IFD. A final version of the manuscript was agreed upon after the groups' findings were presented at a scientific symposium and after a 3-month period for public comment. There were several rounds of discussion before a final version of the manuscript was approved. RESULTS: There is no change in the classifications of "proven," "probable," and "possible" IFD, although the definition of "probable" has been expanded and the scope of the category "possible" has been diminished. The category of proven IFD can apply to any patient, regardless of whether the patient is immunocompromised. The probable and possible categories are proposed for immunocompromised patients only, except for endemic mycoses. CONCLUSIONS: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
引用
- Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis. 2020. PMID: 31802125. doi:10.1093/cid/ciz1008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。